Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT COMPARE: CT Angiography for Plaque Reduction
NCT02740699Phase 4Terminated
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Apr 2016
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, atorvastatin in coronary artery disease (CAD), sponsored by National Heart, Lung, and Blood Institute. Started Apr 2016; status: terminated.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02740699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740699.